AGC Biologics supplies vital lentiviral vector to Autolus Therapeutics.
1 report, 1 independent
Updated Jul 31
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AGC Biologics supplies vital lentiviral vector to Autolus Therapeutics.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
AGC Biologics
Nothing else this week.
-
Autolus Therapeutics
company in London, United Kingdom
Nothing else this week.
Coverage
Newest first; wire copies grouped- Business WireEuropean Commission Approves CAR-T Therapy With Lentiviral Vectors Manufactured by AGC Biologics The Friendly CDMO Expert’s Milan Cell and Gene Center of Excellence Achieves 10th Major Regulatory Pro